Cigna Corporation Q3 2025 Earnings Recap

Cigna Group demonstrated resilient performance in the third quarter of 2025, delivering strong revenue growth of $69.7 billion and adjusted earnings per share of $7.83 while strategically investing in innovation and expanding market access.

Key Takeaways

• Revenue reached $69.7 billion, reflecting robust growth amid ongoing market disruptions.
• Adjusted earnings per share improved to $7.83, bolstered by strategic investments and operational efficiencies.
• Introduced a groundbreaking rebate-free model for pharmacy benefits, aimed at enhancing affordability and consumer experience.
• Completed a strategic investment in Shields Health Solutions to expand addressable markets and position for future growth.
• Demonstrated commitment to improving drug affordability, particularly for generic medications, now accounting for 90% of prescriptions in the U.S.